News

Patented product for the novel treatment of glaucoma is IND-ready FOR IMMEDIATE RELEASE SAN DIEGO, CA, USA (BUSINESS WIRE June 23, 2020) – Today, Leo Lens Pharma, an emerging San Diego-based pharmaceutical company focused on helping protect sight, is pleased to announce that its lead asset,

Accomplished Ophthalmic Executive to Lead Company in Its Next PhaseSAN DIEGO, CA, USA (BUSINESS WIRE April 15, 2020) – Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) is pleased to announce the appointment of Dan Myers as Chief Executive Officer. Prior to joining

Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice

FOR IMMEDIATE RELEASELeo Lens Technology Selected as Finalist for Connect’s 2019 Most Innovative New Product AwardsUnique Drug Delivery Contact Lens Product is a Finalist in the Life Sciences & Healthtech CategorySAN DIEGO, CA, USA (NOVEMBER 11, 2019) – Today, Leo Lens Technology announced that its unique

Leo Lens was featured in a Member Spotlight article from Biocom. Read it here: https://www.biocom.org/corporate-newsletter/newsletter-article/?article=Biocom-Member-Spotlight-Interview-with-Kokila-and-Praful-Doshi-Co-Founders-of-Leo-Lens-Technology